Results 221 to 230 of about 205,880 (261)

Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime-avibactam and intrathecal amikacin.

American Journal of Health-System Pharmacy, 2018
PURPOSE A patient with carbapenem-resistant Klebsiella pneumoniae infection is described, and treatment options are discussed. SUMMARY Few antibiotics to treat carbapenem-resistant Enterobacteriaceae (CRE) infection are available, and treatment is ...
Natalie Gofman, Kim-chung To, Marc S. Whitman, Edgar Garcia-Morales   +3 more
semanticscholar   +1 more source

Amikacin

Reactions Weekly, 2016
  +6 more sources

Amikacin

Reactions Weekly, 2023
openaire   +2 more sources

Breaking the barriers for the delivery of amikacin: Challenges, strategies, and opportunities.

Life Science, 2021
A. Maxwell, V. Ghate, J. Aranjani, S. Lewis   +3 more
semanticscholar   +1 more source

Amikacin

Reactions Weekly, 2014
  +5 more sources

Amikacin

Reactions Weekly, 2018
  +4 more sources

Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia

Journal of Intensive Care Medicine, 2020
F. Najmeddin, B. Shahrami, Sayna Azadbakht, Mehrnoush Dianatkhah, M. Rouini, A. Najafi, A. Ahmadi, H. Sharifnia, M. Mojtahedzadeh   +8 more
semanticscholar   +1 more source

Amikacin

Tuberculosis, 2008
openaire   +2 more sources

Amikacin Sulfate

JAMA: The Journal of the American Medical Association, 1978
openaire   +2 more sources

Amikacin

Reactions Weekly, 1993
openaire   +2 more sources